Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1724350

registered interest
date	30/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to take steps to help ensure mental health services are accessible to patients in rural communities.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	2359
answer	answer is ministerial correction date of answer 02/09/2024 answer text <p>As set out in the NHS Priorities and Operational Planning Guidance for 2024/25, NHS England is continuing to expand access to mental health services, to increase the number of people accessing mental health support. Integrated care boards are responsible for providing health and care services to meet the needs of their local populations.</p><p>We plan to recruit an additional 8,500 mental health workers across child and adult mental health services in England, to reduce delays and provide faster treatment, including in rural areas.</p><p>The Suicide prevention strategy for England: 2023 to 2028, published in September 2023, sets out an ambition to conduct and commission research and data linkage projects, including supporting the Department for Environment, Food and Rural Affairs to look at agricultural workers, to understand the unique challenges in that occupational group and respond appropriately.</p><p>In addition, through its Farming and Countryside Programme, the Department for Environment, Food and Rural Affairs is working with a range of farming charities, including the Royal Agricultural Benevolent Institution and the Yellow Wellies charity, which have highlighted mental health challenges for farming communities.</p> answering member constituency Aberafan Maesteg answering member printed Stephen Kinnock grouped question UIN 2360 question first answered 02/09/2024 11:16:38 answering member 4359 label Biography information for Stephen Kinnock
tabling member	4436 label Biography information for Cat Smith

1724351

registered interest
date	30/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps with representatives from the farming sector to support people with mental health issues in rural communities.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	2360
answer	answer is ministerial correction date of answer 02/09/2024 answer text <p>As set out in the NHS Priorities and Operational Planning Guidance for 2024/25, NHS England is continuing to expand access to mental health services, to increase the number of people accessing mental health support. Integrated care boards are responsible for providing health and care services to meet the needs of their local populations.</p><p>We plan to recruit an additional 8,500 mental health workers across child and adult mental health services in England, to reduce delays and provide faster treatment, including in rural areas.</p><p>The Suicide prevention strategy for England: 2023 to 2028, published in September 2023, sets out an ambition to conduct and commission research and data linkage projects, including supporting the Department for Environment, Food and Rural Affairs to look at agricultural workers, to understand the unique challenges in that occupational group and respond appropriately.</p><p>In addition, through its Farming and Countryside Programme, the Department for Environment, Food and Rural Affairs is working with a range of farming charities, including the Royal Agricultural Benevolent Institution and the Yellow Wellies charity, which have highlighted mental health challenges for farming communities.</p> answering member constituency Aberafan Maesteg answering member printed Stephen Kinnock grouped question UIN 2359 question first answered 02/09/2024 11:16:38 answering member 4359 label Biography information for Stephen Kinnock
tabling member	4436 label Biography information for Cat Smith

1721322

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of restricting puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	87
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The emergency banning Order, restricting the sale or supply of puberty blockers, was introduced by the previous Government. The Order enables those who were already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues, before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.</p><p>The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This Government will always act in the interests of patient safety, which is why the Secretary of State signalled his intention to renew the Order and consult on a permanent ban (subject to the outcome of the ongoing judicial review).</p><p>We are committed to implementing the recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institute of Health and Care Research, the research arm of the Department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.</p><p>We will continue to monitor the impacts of the Order, including on mental health. Professor Louis Appleby, Chair of the National Suicide Prevention Strategy Advisory Group, has examined evidence for a large rise in suicides claimed by campaigners. His paper, which was published on 19 July 2024, concluded that the data do not support the claim that there has been a large rise in suicide in young gender dysphoria patients at the Tavistock clinic.</p><p>Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People’s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:</p><p><a href="https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/" target="_blank">https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/</a></p><p>Professor Appleby’s paper is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust-independent-report" target="_blank">https://www.gov.uk/government/publications/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust-independent-report</a></p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne grouped question UIN 109 91 question first answered 29/07/2024 13:55:40 answering member 1506 label Biography information for Andrew Gwynne
tabling member	4436 label Biography information for Cat Smith

1721323

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ensure that those proscribed puberty blockers for the treatment of gender incongruence will continue to receive them.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	88
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The emergency banning order limiting the sale or supply of puberty blockers against private or non-United Kingdom prescriptions allows a child under 18 years old, who was already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.</p><p>This government has committed to implementing the expert recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institue of Health and Care Research – the research arm of the department – are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.</p><p>Children and young people unable to access puberty blockers are strongly advised to meet with their clinician. We expect clinicians to be working with impacted patients to consider what the best care for them is going forward. Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People’s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:</p><p><a href="https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/" target="_blank">https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/</a></p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 29/07/2024 14:33:23 answering member 1506 label Biography information for Andrew Gwynne
tabling member	4436 label Biography information for Cat Smith

1721324

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made a comparative assessment of the UK’s position on the prescription of puberty blockers for the treatment of gender incongruence with that of other European countries.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	89
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The Cass Review is one of the most comprehensive reviews of gender identity services for children and young people to date worldwide.</p><p>The Cass review included an assessment of evidence from other countries and concluded that there was a lack of evidenced-based guidelines and, therefore, limitations for adopting these for National Health Service gender services. Informed by the Cass review, we are now reforming transgender care for young people in this country, based on the best possible evidence. That means a holistic approach, with puberty suppressing hormones only considered within a much broader needs assessment, and only then in the context of a clinical trial. We are committed to implementing the recommendations of the Cass Review, as that is the care model we believe to be the best approach in the interests of patient safety.</p><p>It is simply not possible for pharmacists to check whether prescriptions issued from overseas registered prescribers have been issued in a similarly safe and effective way, and we know that some overseas providers who advertise their services do not follow this approach.</p> answering member constituency Bristol South answering member printed Karin Smyth question first answered 29/07/2024 14:25:58 answering member 4444 label Biography information for Karin Smyth
tabling member	4436 label Biography information for Cat Smith

1721325

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his timetable is for the clinical trial being conducted on the use of puberty blockers for the treatment of gender incongruence.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	90
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This is why NHS England and the National Institute of Health and Care Research, the research arm of the department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.</p> answering member constituency Bristol South answering member printed Karin Smyth grouped question UIN 443 question first answered 29/07/2024 14:21:24 answering member 4444 label Biography information for Karin Smyth
tabling member	4436 label Biography information for Cat Smith

1721326

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential risks of harm being caused by restrictions on puberty blockers for treatments of gender incongruence.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	91
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The emergency banning Order, restricting the sale or supply of puberty blockers, was introduced by the previous Government. The Order enables those who were already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues, before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.</p><p>The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This Government will always act in the interests of patient safety, which is why the Secretary of State signalled his intention to renew the Order and consult on a permanent ban (subject to the outcome of the ongoing judicial review).</p><p>We are committed to implementing the recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institute of Health and Care Research, the research arm of the Department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.</p><p>We will continue to monitor the impacts of the Order, including on mental health. Professor Louis Appleby, Chair of the National Suicide Prevention Strategy Advisory Group, has examined evidence for a large rise in suicides claimed by campaigners. His paper, which was published on 19 July 2024, concluded that the data do not support the claim that there has been a large rise in suicide in young gender dysphoria patients at the Tavistock clinic.</p><p>Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People’s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:</p><p><a href="https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/" target="_blank">https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/</a></p><p>Professor Appleby’s paper is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust-independent-report" target="_blank">https://www.gov.uk/government/publications/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust-independent-report</a></p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne grouped question UIN 109 87 question first answered 29/07/2024 13:55:40 answering member 1506 label Biography information for Andrew Gwynne
tabling member	4436 label Biography information for Cat Smith

1721327

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will meet with (a) young trans young people and (b) their families to discuss the prescription of puberty blockers for the treatment of gender incongruence.
tabling member constituency	Lancaster and Wyre
tabling member printed	Cat Smith
uin	92
answer	answer is ministerial correction date of answer 29/07/2024 answer text <p>The emergency banning order limiting the sale or supply of puberty blockers against private or non-United Kingdom prescriptions allows a child under 18 years old, who was already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.</p><p>This government has committed to implementing the expert recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institue of Health and Care Research – the research arm of the department – are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.</p><p>We recognise the value of engaging with representative groups and want to reset the relationship the department has with LGBT+ groups. My rt. Hon. Friend, the Secretary of State for Health and Social Care, will be meeting with LGBT+ stakeholders as soon as possible to hear directly about the health and care issues that are most important to them.</p> answering member constituency Bristol South answering member printed Karin Smyth question first answered 29/07/2024 14:19:06 answering member 4444 label Biography information for Karin Smyth
tabling member	4436 label Biography information for Cat Smith

1715999

registered interest
date	07/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Leukaemia: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to improve research into acute myeloid leukaemia.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	24951
answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>The Department is proud to invest £1.3 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was over £121.8 million for 2022/23, and more is spent on cancer than any other disease group.</p><p> </p><p>The Government, through the NIHR, is committed to improving research into the cancers with the poorest survival rates, such as acute myeloid leukaemia, by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer, and other less survivable cancers. The following table shows NIHR research spend on diagnosis, treatment, and diagnosis and treatment of blood cancers, which includes leukaemia, since 2018:<br></p><table><tbody><tr><td><p>Number of projects</p></td><td><p>Total awards value</p></td></tr><tr><td><p>Blood cancer diagnosis</p></td><td><p>11</p></td><td><p>£11,900,000</p></td></tr><tr><td><p>Blood cancer treatment</p></td><td><p>14</p></td><td><p>£14,700,000</p></td></tr><tr><td><p>Blood cancer diagnosis and treatment</p></td><td><p>4</p></td><td><p>£7,700,000</p></td></tr></tbody></table><p><br> In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council’s two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p><br> The NIHR continues to encourage and welcome applications for research into any aspect of human health, including acute myeloid leukaemia. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals, and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers, made through open competition, have been funded.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/05/2024 13:32:26 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4436 label Biography information for Cat Smith

1713924

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Lancaster and Wyre
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of the GP to patient ratio in Wyre.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	23755
answer	answer is ministerial correction date of answer 03/05/2024 answer text <p>In March 2024, the median general practice patient ratio in Wyre was 5.1 full time equivalent doctors in general practice per 10,000 registered patients.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 03/05/2024 08:22:24 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4436 label Biography information for Cat Smith